Enzyme Regulation: Zymogen Activation Indian Medical PG Practice Questions and MCQs
Practice Indian Medical PG questions for Enzyme Regulation: Zymogen Activation. These multiple choice questions (MCQs) cover important concepts and help you prepare for your exams.
Enzyme Regulation: Zymogen Activation Indian Medical PG Question 1: Digestion of proteins is initiated by:
- A. Amylase
- B. Sucrase
- C. Chymotrypsin
- D. Pepsin (Correct Answer)
Enzyme Regulation: Zymogen Activation Explanation: ***Pepsin***
- **Pepsin** is the primary enzyme responsible for initiating **protein digestion** in the **stomach**.
- It cleaves proteins into smaller polypeptides, functioning optimally in the highly **acidic environment** of the stomach.
*Amylase*
- **Amylase** is responsible for the digestion of **carbohydrates**, breaking down starch into simpler sugars.
- It is found in both saliva (salivary amylase) and pancreatic secretions (pancreatic amylase), and does not act on proteins.
*Sucrase*
- **Sucrase** is an enzyme located in the **small intestine** and is responsible for breaking down the disaccharide **sucrose** into glucose and fructose.
- It plays no role in protein digestion.
*Chymotrypsin*
- **Chymotrypsin** is a proteolytic enzyme secreted by the **pancreas** that acts in the **small intestine** to further digest polypeptides into smaller peptides.
- While it digests proteins, it is not the *initiating* enzyme; protein digestion is already underway by the time chymotrypsin acts.
Enzyme Regulation: Zymogen Activation Indian Medical PG Question 2: A patient presents with respiratory distress and is diagnosed with panacinar emphysema. Which of the following is deficient?
- A. Alpha-1 antitrypsin (Correct Answer)
- B. Surfactant
- C. Albumin
- D. Type II pneumocytes
Enzyme Regulation: Zymogen Activation Explanation: **Alpha-1 antitrypsin**
* **Alpha-1 antitrypsin (A1AT) deficiency** is a genetic disorder that leads to the development of panacinar emphysema, especially in non-smokers or at a young age [1], [2].
* A1AT protects the lung tissue from destruction by **elastase** released by neutrophils; without it, this enzyme breaks down alveolar walls [1], [2].
*Surfactant*
* **Surfactant** is responsible for reducing surface tension in the alveoli, preventing their collapse in the lungs.
* A deficiency primarily causes **neonatal respiratory distress syndrome** or adult respiratory distress syndrome, not predominantly emphysema.
*Albumin*
* **Albumin** is a primary protein in plasma that maintains oncotic pressure and transports various substances in the blood.
* A deficiency in albumin (e.g., in liver disease or malnutrition) typically leads to **edema** and impaired drug transport, not emphysema.
*Type II pneumocytes*
* **Type II pneumocytes** are responsible for producing and secreting surfactant, as well as acting as progenitor cells for Type I pneumocytes.
* While abnormalities in these cells can lead to surfactant deficiency, the direct cause of genetic panacinar emphysema is the lack of protection against elastase, not a primary defect in pneumocyte number or function in this context.
Enzyme Regulation: Zymogen Activation Indian Medical PG Question 3: Which of the following statements best describes the mechanism of action of insulin on target cells?
- A. Insulin binds to a receptor on the outer surface of the plasma membrane, activating adenylate cyclase through the Gs protein.
- B. Insulin binds to a cytoplasmic receptor and is transferred as a hormone receptor complex to the nucleus to modulate gene expression.
- C. Insulin enters the cell and causes the release of calcium ions from intracellular stores.
- D. Insulin binds to a transmembrane receptor on the outer surface of the plasma membrane, activating the tyrosine kinase in the cytosolic domain of the receptor. (Correct Answer)
Enzyme Regulation: Zymogen Activation Explanation: ***Insulin binds to a transmembrane receptor on the outer surface of the plasma membrane, activating the tyrosine kinase in the cytosolic domain of the receptor.***
- **Insulin** is a **peptide hormone** and cannot freely pass through the lipid bilayer, thus it binds to a **transmembrane receptor** on the cell surface.
- This binding leads to the activation of the receptor's intrinsic **tyrosine kinase activity** in the intracellular domain, initiating a signaling cascade.
*Insulin binds to a cytoplasmic receptor and is transferred as a hormone receptor complex to the nucleus to modulate gene expression.*
- This mechanism describes the action of **steroid hormones**, which are lipid-soluble and can cross the cell membrane, binding to **intracellular receptors**.
- **Insulin** acts via a **cell surface receptor** and its downstream effects are mediated through signal transduction pathways, not direct nuclear translocation.
*Insulin binds to a receptor on the outer surface of the plasma membrane, activating adenylate cyclase through the Gs protein.*
- This mechanism is characteristic of **G-protein coupled receptors (GPCRs)**, which activate or inhibit enzymes like adenylate cyclase via G-proteins to produce second messengers like cyclic AMP.
- The **insulin receptor** is a **receptor tyrosine kinase**, not a GPCR, and does not directly activate adenylate cyclase via Gs protein.
*Insulin enters the cell and causes the release of calcium ions from intracellular stores.*
- While some hormones and neurotransmitters can trigger the release of intracellular **calcium ions**, this is typically mediated by specific pathways (e.g., GPCRs linked to phospholipase C).
- **Insulin** does not directly enter target cells to cause calcium release; its actions are primarily mediated through receptor tyrosine kinase signaling pathways.
Enzyme Regulation: Zymogen Activation Indian Medical PG Question 4: A 35-year-old woman with a long history of dyspnea, chronic cough, sputum production, and wheezing dies of respiratory failure following a bout of lobar pneumonia. She was not a smoker or an alcoholic. Which of the following underlying conditions is most likely associated with the pathologic changes shown in the lung autopsy?
- A. Antibodies against type 4 collagen (associated with Goodpasture syndrome)
- B. Cystic fibrosis (a genetic disorder affecting the lungs)
- C. Mutation in dynein arms (associated with primary ciliary dyskinesia)
- D. Alpha-1 antitrypsin deficiency (Correct Answer)
Enzyme Regulation: Zymogen Activation Explanation: ***Alpha 1 antitrypsin deficiency***
- This condition leads to **accumulation of abnormal protein** in the liver and lungs, resulting in emphysema, which is consistent with chronic cough and dyspnea [1].
- Patients often develop **lung pathology** similar to what is seen in smokers, making it plausible given the patient's background [1].
*Mutation in dynein arms*
- This is associated with **primary ciliary dyskinesia**, which presents with recurrent respiratory infections but is not typical in non-smokers or in the context of **dyspnea with chronic cough**.
- Usually linked to **situs inversus** and **recurrent infections**, neither of which is highlighted here.
*Antibodies against type 4 collagen*
- This condition is related to **Goodpasture syndrome**, which typically results in **hemoptysis** and **renal failure**, rather than chronic cough and sputum production.
- The predominant involvement in this syndrome does not align with the clinical presentation of **chronic lung disease** noted in this patient.
*Cystic fibrosis*
- While it causes **chronic respiratory symptoms**, it is usually seen in younger patients and is associated with **pancreatic insufficiency** and **salty sweat**.
- The age of the patient and symptom progression does not fit well with a diagnosis of cystic fibrosis.
**References:**
[1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lung, pp. 683-684.
Enzyme Regulation: Zymogen Activation Indian Medical PG Question 5: Inactive precursors of enzymes are known as:
- A. Apoenzymes
- B. Coenzymes
- C. Proenzymes (Correct Answer)
- D. Holoenzymes
Enzyme Regulation: Zymogen Activation Explanation: ***Proenzymes***
- **Proenzymes**, also known as **zymogens**, are inactive precursor forms of enzymes that require a biochemical change (e.g., proteolytic cleavage) to become active.
- This mechanism allows for the **controlled activation** of enzymes, preventing premature or inappropriate enzymatic activity.
*Apoenzymes*
- An **apoenzyme** is the protein component of an enzyme that requires a **non-protein cofactor** (like a metal ion or coenzyme) to become active.
- It describes the enzyme without its essential cofactor, making it inactive until the cofactor binds.
*Coenzymes*
- **Coenzymes** are small, non-protein organic molecules that bind to apoenzymes to assist in catalysis.
- They often function as **carriers of electrons, atoms, or functional groups** during enzymatic reactions.
*Holoenzymes*
- A **holoenzyme** is the catalytically active form of an enzyme, consisting of an **apoenzyme** (protein part) combined with its essential **cofactor** (e.g., coenzyme or metal ion).
- It represents the complete and functional enzyme complex.
Enzyme Regulation: Zymogen Activation Indian Medical PG Question 6: All of the following are true about blood coagulation, except which of the following?
- A. Factor X directly activates both intrinsic and extrinsic pathways. (Correct Answer)
- B. Calcium is required in several steps of coagulation.
- C. Extrinsic pathway is activated by tissue factor released from damaged tissues.
- D. Intrinsic pathway can be activated in vitro by contact with collagen.
Enzyme Regulation: Zymogen Activation Explanation: ***Extrinsic pathway is activated by contact with negatively charged surfaces***
- The **extrinsic pathway** is actually activated by tissue factor, not by contact with negatively charged surfaces [1].
- This statement is therefore **incorrect**, making it the exception among the other statements.
*Factor X is part of both intrinsic and extrinsic pathways*
- Factor X is indeed a key component involved in both the **intrinsic** and **extrinsic pathways** of coagulation, leading to the common pathway [1].
- The presence of Factor X is crucial for the conversion of prothrombin to thrombin in both pathways [2].
*Calcium is required in several steps of coagulation*
- Calcium (**factor IV**) is essential for several reactions in the coagulation cascade, playing a pivotal role in both pathways [1].
- It acts as a cofactor that facilitates various enzyme-substrate interactions necessary for the coagulation process [2].
*Intrinsic pathway can be activated in vitro*
- The **intrinsic pathway** can be activated in vitro using substances like kaolin or glass that promote contact activation [1].
- This means the statement is not an exception, as it's true regarding the properties of the intrinsic pathway.
**References:**
[1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Hemodynamic Disorders, Thromboembolic Disease, and Shock, pp. 128-130.
[2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Blood And Bone Marrow Disease, pp. 582-583.
Enzyme Regulation: Zymogen Activation Indian Medical PG Question 7: Which of the following is an example of allosteric inhibition?
- A. Decreased synthesis of glucokinase by glucagon
- B. Inactivation of glycogen synthase by phosphorylation
- C. Inhibition of PFK-1 by citrate (Correct Answer)
- D. None of the options
Enzyme Regulation: Zymogen Activation Explanation: ***Inhibition of PFK-1 by citrate***
- **Citrate** acts as an **allosteric inhibitor** of **phosphofructokinase-1 (PFK-1)**, a key enzyme in glycolysis.
- Citrate binds to a site distinct from the active site, inducing a conformational change that reduces PFK-1's affinity for **fructose-6-phosphate**, thus slowing glycolysis.
*Inactivation of glycogen synthase by phosphorylation*
- This is an example of **covalent modification** (phosphorylation), not allosteric regulation.
- Phosphorylation alters the enzyme's activity by adding a phosphate group, changing its structure and function.
*Decreased synthesis of glucokinase by glucagon*
- This describes **transcriptional regulation** or **gene expression control**, where glucagon affects the amount of enzyme produced.
- It is not an example of allosteric regulation, which involves direct binding of a molecule to an enzyme to alter its activity.
*None of the options*
- This option is incorrect because the inhibition of PFK-1 by citrate is a classic example of allosteric inhibition.
Enzyme Regulation: Zymogen Activation Indian Medical PG Question 8: How do enzymes function in biochemical reactions?
- A. Increase in activation energy
- B. Decrease in activation energy (Correct Answer)
- C. Shift equilibrium constant
- D. Provide energy to the reaction
Enzyme Regulation: Zymogen Activation Explanation: ***Decrease in activation energy***
- Enzymes act as **biological catalysts** by providing an alternative reaction pathway with a lower **transition state energy**.
- This reduction in the **activation energy** allows a higher proportion of reactant molecules to overcome the energy barrier and react, thereby increasing the reaction rate.
*Increase in activation energy*
- This statement is incorrect as increasing activation energy would slow down the reaction rate, which is contrary to the function of enzymes.
- Enzymes are designed to accelerate reactions, not inhibit them, by making them energetically more favorable to proceed.
*Shift equilibrium constant*
- Enzymes catalyze both the forward and reverse reactions equally, meaning they accelerate the rate at which equilibrium is reached but **do not alter the equilibrium constant (Keq)** of a reaction.
- The equilibrium constant is determined by the difference in free energy between reactants and products, which enzymes do not change.
*Provide energy to the reaction*
- This statement is incorrect because enzymes do **not provide energy** to reactions; they only lower the activation energy barrier.
- Enzymes facilitate reactions by stabilizing the transition state, not by adding energy to the system, which would violate thermodynamic principles.
Enzyme Regulation: Zymogen Activation Indian Medical PG Question 9: Enzyme activity is expressed as?
- A. Millimoles/lit
- B. Milli gm/lit
- C. Mg/dl
- D. Micromoles/min (Correct Answer)
Enzyme Regulation: Zymogen Activation Explanation: ***Micromoles/min***
- Enzyme activity is typically measured by the rate at which an enzyme converts its **substrate into product**.
- This rate is often expressed as the amount of product formed (e.g., **micromoles**) or substrate consumed per unit of time (e.g., **per minute**).
*Millimoles/lit*
- This unit expresses **concentration** (moles per liter) rather than a rate of reaction.
- While enzyme reactions involve changes in substrate/product concentration, this unit alone does not describe the **activity or catalytic speed** of the enzyme.
*Milli gm/lit*
- This unit also expresses **concentration by mass** (milligrams per liter), not enzyme activity.
- It does not account for the **time-dependent nature** of enzyme catalysis or the molar quantity of reactants/products.
*Mg/dl*
- This unit represents **concentration by mass** (milligrams per deciliter), commonly used for measuring substances like glucose or cholesterol in blood.
- It is not appropriate for expressing the **catalytic rate or activity** of an enzyme.
Enzyme Regulation: Zymogen Activation Indian Medical PG Question 10: What is the specific activity of an enzyme?
- A. Enzyme units per mg of protein (Correct Answer)
- B. Concentration of substrate transformed per minute
- C. Enzyme units per mg of substrate
- D. Limit of enzyme per gram of substrate
Enzyme Regulation: Zymogen Activation Explanation: ***Enzyme units per mg of protein***
- **Specific activity** is defined as the number of **enzyme units** (representing catalytic activity) per milligram of total protein in the sample.
- It is a measure of **purity**, indicating the amount of active enzyme relative to other proteins in a preparation.
- Formula: Specific activity = Units of enzyme activity / mg of total protein
- Used to track enzyme purification progress during isolation procedures.
*Concentration of substrate transformed per minute*
- This describes the **reaction velocity** or rate of catalysis, but not the specific activity of the enzyme.
- While related to enzyme activity, it does not normalize the activity to the amount of **total protein**.
- This would be expressed as reaction rate or velocity (V), not specific activity.
*Enzyme units per mg of substrate*
- This is an incorrect formulation that confuses substrate with protein.
- **Specific activity** is normalized to the amount of **protein** in the enzyme preparation, not the substrate.
- This option represents a common misconception in enzyme kinetics terminology.
*Limit of enzyme per gram of substrate*
- This phrase does not correspond to any standard biochemical measure of enzyme activity or concentration.
- It does not provide information about the **catalytic efficiency** or **purity** of the enzyme preparation.
- The term "limit" is not used in the context of specific activity measurements.
More Enzyme Regulation: Zymogen Activation Indian Medical PG questions available in the OnCourse app. Practice MCQs, flashcards, and get detailed explanations.
